|
SPAG9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.045800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.184400E-02 |
| Normal-vs-Stage2 |
8.089800E-01 |
| Normal-vs-Stage3 |
2.166000E-02 |
| Normal-vs-Stage4 |
1.935560E-02 |
| Stage1-vs-Stage2 |
2.127200E-01 |
| Stage1-vs-Stage3 |
3.590800E-04 |
| Stage1-vs-Stage4 |
7.606000E-04 |
| Stage2-vs-Stage3 |
1.714230E-01 |
| Stage2-vs-Stage4 |
1.343980E-01 |
| Stage3-vs-Stage4 |
7.792200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.189400E-01 |
| Normal-vs-AfricanAmerican |
1.845810E-01 |
| Normal-vs-Asian |
2.212400E-01 |
| Caucasian-vs-AfricanAmerican |
2.208400E-01 |
| Caucasian-vs-Asian |
4.346200E-01 |
| AfricanAmerican-vs-Asian |
2.095000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.545430E-01 |
| Normal-vs-Female |
1.963040E-01 |
| Male-vs-Female |
8.380100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.054400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.327000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.123200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.336800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.217000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.103050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.878190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.510400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.990200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.448000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.251600E-02 |
| Normal-vs-Grade 2 |
1.705830E-01 |
| Normal-vs-Grade 3 |
4.870000E-01 |
| Normal-vs-Grade 4 |
3.19619999999965E-06 |
| Grade 1-vs-Grade 2 |
3.789800E-02 |
| Grade 1-vs-Grade 3 |
5.503800E-03 |
| Grade 1-vs-Grade 4 |
1.200620E-03 |
| Grade 2-vs-Grade 3 |
4.584400E-02 |
| Grade 2-vs-Grade 4 |
1.58909999603551E-08 |
| Grade 3-vs-Grade 4 |
1.037590E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.83931999999665E-05 |
| Normal-vs-ccB subtype |
2.380500E-04 |
| ccA subtype-vs-ccB subtype |
2.65343302885412E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.374600E-01 |
| Normal-vs-N1 |
8.169700E-02 |
| N0-vs-N1 |
9.524400E-02 |
|
|
